Morningstar

Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation | Morningstar

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced clinical data ...
Nature

Pulsed electric field ablation process-the effect of bifurcation stents on electric field and heat distribution

Pulsed field ablation (PFA) is a novel non-thermal technique for arrhythmia treatment, capable of targeting the epicardium. However, the effects of coronary bifurcation lesions (BL) and bifurcation ...
Healio

Pulsed field ablation as first-line treatment superior to drug therapy in persistent AF

Please provide your email address to receive an email when new articles are posted on . In patients with persistent AF, pulsed field ablation was better than drug therapy at preventing arrhythmia ...